The Future of Drug Pricing
Could global pressure on health spending force the pharmaceutical industry to embrace pricing drugs based on clinical outcomes instead of
Read MoreCould global pressure on health spending force the pharmaceutical industry to embrace pricing drugs based on clinical outcomes instead of
Read More(By Maurie Markman for STAT) Data sharing is one of the “next big things” in cancer research. This essential extension
Read More(By Rachel Bluth for Kaiser Health News) Assisted living residents who abuse other residents or staff are likely to have
Read MoreDo you know the seven strategies to consider that could help lower your Medicare prescription drug costs such as: stay
Read More(By Helen Branswell for STAT) About a year ago, before the Zika virus grabbed global attention, there were zero vaccines
Read More(By Ed Silverman for STAT) In the latest contest over biosimilars, AbbVie has filed a patent infringement lawsuit against Amgen,
Read More(By Ed Silverman for STAT) More than a year after spending roughly $17 billion to acquire Hospira, Pfizer is finding
Read More(By Carmen Heredia Rodriguez for Kaiser Health News) Luis Ascanio, 61, works as a medical interpreter at La Clinica del
Read More(By Shefali Luthra for Kaiser Health News) You have your red pill and your green pill. There’s the one you
Read More(By Anna Gorman for Kaiser Health News) SAN FRANCISCO — Janet Prochazka was active and outspoken, living by herself and
Read More